Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

No pharmacological treatment affecting lipid metabolism or glucose
Normal aminotransferases
No systemic diseases
...
No pharmacological treatment affecting lipid metabolism or glucose
Normal aminotransferases
No systemic diseases
Signed Informed consent and assent
Pc BMI ≥ 95 and <35kg/m2,
No history of acute or prolonged immobilization
No genetic diseases
No endocrine diseases, including diabetes mellitus
Patients of both sexes between 8 and 18 years old

Summary

Conditions
Obesity
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Investigator)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 8 years and 18 years
Gender
Both males and females

Inclusion Criteria

No pharmacological treatment affecting lipid metabolism or glucose
Normal aminotransferases
No systemic diseases
...
No pharmacological treatment affecting lipid metabolism or glucose
Normal aminotransferases
No systemic diseases
Signed Informed consent and assent
Pc BMI ≥ 95 and <35kg/m2,
No history of acute or prolonged immobilization
No genetic diseases
No endocrine diseases, including diabetes mellitus
Patients of both sexes between 8 and 18 years old

Tracking Information

NCT #
NCT02063802
Collaborators
Hospital General de Mexico
Investigators
  • Principal Investigator: Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México
  • Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México